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ABSTRACT
Herpesvirus saimirÃ-strain 11 and attenuated H. saimirÃ-strain
11 proteins synthesized during the lytic cycle of virus replication
were used for immunoprecipitation with various sera from natural
(SaimirÃ-sciureus) and experimental (Saguinus nigricollis, Sa-
guinus fuscicollis, Aotus trivirgatus, New Zealand White rabbits)
hosts. The analysis of the precipitates separated in sodium
dodecyl sulfate:polyacrylamide gels revealed that in tumor-de
veloping animals a specific set of viral polypeptides were precip
itated, which were not precipitated by sera obtained from the
natural host SaimirÃ-sciureus. Using labeled proteins from H.
saimirÃ-11 and its attenuated strain, respectively, a difference
was shown after precipitation with a serum raised against in
fected cell proteins of H. saimirÃ-11.
INTRODUCTION
Marmosets of the genus Saguinus (Saguinus oedipus, Sa
guinus nigricollis, Saguinus fuscicollis) are highly susceptible to
tumor induction by Herpesvirus saimirÃ- and develop a fatal,
rapidly growing neoplastic disease (3, 11) following virus infec
tion. Owl monkeys (Aotus trivirgatus) show a similar course of
disease. The appearance of tumors in these animals is often
delayed, and about 20% of the owl monkeys infected with H.
saimirÃ-do not develop tumors (7,10). H. sa/m/n'-infected NZWR3
show a disease pattern similar to that of primates; the incidence
of neoplastic disease after infection with H. saimirÃ-varies be
tween about 20 and 75% in different studies (1, 2,16). In squirrel
monkeys (SaimirÃ-sciureus), the natural hosts of H. saimirÃ-are
inapparently infected and are lifelong virus carriers.
In our study, we tested the specificity of antibodies in the
various experimental and natural hosts by immunoprecipitation
of viral polypeptides obtained from OMK cells infected with
H. saimirÃ-strain 11 or an attenuated mutant of H. saimirÃ-11(H. saimirÃ--\Ã¬att)(17).
MATERIALS AND METHODS
Cells. OMK cells were cultured in 32-ounce glass prescription bottles
or plastic Retri plates using MEM (Earle's salts; Grand Island Biological
Co.) supplemented with 20 mw glutamine, penicillin (100 units/ml), strep
tomycin (100 Mg/ml), and 10% heat-inactivated fetal calf serum (Seromed,
Munich, Germany).
Virus. H. saimirÃ-11 was originally obtained from B. Fleckenstein
1This work was supported by the Deutsche Forschungsgemeinschaft SFB 51,
TP A21, and A24 and by Wo 227/2.
2To whom requests for reprints should be addressed.
3The abbreviations used are: NZWR, New Zealand White rabbit; OMK cells,
owl monkey kidney cells; MEM, minimal essential medium; PFU, plaque-forming
units; i.e., intracutaneously; SDS, sodium dodecyl sulfate; p152, protein with a
molecular weight of 152,000 (other proteins are designated similarly); p.i., postin-
fection; EA. early antigen.
Received December 20,1982; accepted April 8,1983.
(University of Erlangen, Erlangen, Germany), the attenuated Herpesvirus
saimirÃ-(H. saimirÃ-11 att) mutant was a gift of F. Deinhardt (Max von
Pettenkofer-lnstitute). Cells were infected with H. saimirÃ-at 1 to 2 PFU/
cell; after an adsorption period of 2 hr at room temperature, the cultures
were replenished with MEM supplemented with 2% heat-inactivated fetal
calf serum and phorbol-12-myristate-13-acetate (20 ng/ml; Sigma, Mu
nich, Germany) (12) and incubated at 34Â°until a pronounced cytopathic
effect became visible (12).
Sera. The sera of squirrel monkeys (Ss 1, Ss 2, Ss 3) and owl
monkeys (At 1, At 2, At 3) were a gift of L. Falk, New England Primate
Research Center, Southborough, Mass. The S. nigricollis serum (Sn 1)
was obtained from a monkey which had died of a neoplastic disease 7
weeks after inoculation i.m. with 1 x 106 PFU H. saimirÃ- 11. The S.
fuscicollis serum (Sf 1) was infected with H. saimirÃ-11 att and developed
a lifelong virus carrier status without showing any signs of disease; the
serum was obtained 7 years after inoculation (gift of F. Deinhardt). The
rabbit (NZWR1) was inoculated i.v. with 1 x 106 PFU H. saimirÃ-11 and
died 3 weeks after inoculation. A serum against viral structural proteins
was obtained from a rabbit (R 1) inoculated i.e. with multiple doses of
purified H. saimirÃ- 11 particles in the presence of complete Freund's
adjuvant. A serum against virus-induced infected cell proteins was ob
tained from a goat inoculated with multiple doses of H. saimirÃ-11-infected
cells (gift of F. Deinhardt).
Labeling of Proteins Synthesized by Infected OMK Cells and
Preparation of Cell Extracts. OMK cells were infected at 90% con-
fluency with H. saimirÃ-11 or H. saimirÃ-11 att and labeled at various times
after infection with [35S]methionine (20 Â¿iCi/ml; Amersham Buchler,
Braunschweig, Germany) in methionine-free MEM. A set of early proteins
was accumulated by the addition of azetidine (500 ng/ml; Sigma). At the
end of the labeling period, cells were rinsed 3 times with cold phosphate-
buffered saline (140 ITIMNaCI, 3 rriM KCI, 0.75 mw Na2PO4, 1 mM CaCI2,
5 mM MgCli) to stop incorporation of amino acids, solubilized in immu
noprecipitation buffer (0.5 ml/1 x 106 infected cells, 1% Triton X-100,
0.1% SDS, 0.137 M NaCI, 1 mM CaCI2, 1 mw MgCI2, 10% glycerol, 20
mM Tris-HCI (pH 9.0), 0.01% NaN3, phenylmethylsulfonyl fluoride (1 ng/
ml; Sigma)], and disrupted by sonication (Branson sonifier). The extracts
were clarified by centrifugation at 100,000 x g for 30 min at 4Â°and
stored at -20Â°.
Immunoprecipitation and Electrophoresis. In order to remove anti
bodies against cellular proteins, 10 v\ of each serum were incubated with
0.5 ml of an extract of uninfected, unlabelled OMK cells (1 x 107 cells/
ml, prepared as described above) overnight at 4Â°.Protein A-Sepharose
beads (3 mg; Pharmacia, Freiburg, Germany), preswollen in 100 n\
immunoprecipitation buffer, were added, and the reaction was incubated
at 4Â°for another 2 hr. Labeled protein extract (0.3 ml) was added, and
the immunocomplexes were allowed to form during a 3-hr incubation
period at room temperature. The beads were washed with immunopre
cipitation buffer until supernatants contained no detectable radioactivity.
The washed beads were resuspended in electrophoresis sample buffer
[50 mM Tris-HCI (pH 7.0), 2% SDS, 5% mercaptoethanol, 3% su
crose: bromophenol blue] and heated to 100Â°for 5 min to dissociate the
immune complexes. The supernatant was analyzed on 10%
SDS:polyacrylamide gels; 10,000 cpm were applied per slot, when
available. Electrophoresis was done in a discontinuous buffer system (9)
on slab gels. The separating gel contained 10% acrylamide, 0.26%
diallyltartardiimide, 0.1% SDS, and 375 mM Tris-HCI (pH 8.5). Polymeri
zation was initiated by adding ammonium persulfate to a final concentra-
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tion of 0.14 mW and A/,A/,A/',A/'-tetraethylmethylenediamine to a final
concentration of 0.035%. The stacking gel contained 3% acrylamide,
0.08% diallyltartardiimide, 0.1% SDS, and 120 rnw Tris-HCI, pH 7.O. The
upper and lower buffer tanks contained 25 rriM Tris-HCI (pH 8.5), 192
mw glycine, and 0.1 % SDS. Electrophoresis was performed at a constant
current of 5.3 ma/sq cm until the leading front reached the end of the
gel. Gels were fixed and stained in wateracetic acid:isopropyl alcohol
(4:1:1), destained in wateracetic acid:isopropyl alcohol (8:1:1), and dried
onto Whatman No. 2MM filter paper under vacuum. All chemicals were
purchased from Bio-Rad (Munich, Germany); high-molecular-weight
standards from the same company were used as markers. Gels were
exposed to 3H-Ultrofilm (LKB, GrÃ¤felfing, Germany).
RESULTS
Precipitation with SaimirÃ-sciureus Sera. H. sa/m/ri-infected
cell proteins were labeled at early (6 to 8 hr p.i.), middle (15 to
17 hr p.i.), and late (24 to 26 hr p.i.) times and in the presence
of azetidine (500 MQ/ml) with [35S]methionine. The labeled poly-
peptides were precipitated with 3 different sera of squirrel mon
keys (Ss 1, Ss 2, Ss 3). In azetidine-treated cells (Fig. 1) and at
early times after infection, only a few viral proteins could be
precipitated: p152, p53, p50, and p28 (Fig. 1) and p152, p97,
p53, and p46 (Fig. 2). When proteins were labeled at middle (not
shown) and late times (Fig. 3) after infection, a subset of viral
polypeptides was identified, composed of mostly viral structural
proteins (13) produced at the end of the lytic cycle: p195, p152,
p146, p135, p127, p123, p106, p97, p88, p67, p61, p53, p50,
p28 (12). A serum against virion proteins produced in rabbits (R
1) was used as positive control. All sera were tested with mock-
infected cells to rule out unspecific binding (data not shown).
Precipitation with Sera of Experimental Hosts. [35S]Methio-
nine-labeled proteins were precipitated with 3 different owl mon
key sera (At 1, At 2, At 3), with one S. nigricollis (Sn 1) serum,
and one NZWR (NZWR 1) serum from animals which were dying
of neoplastic disease after infection with H. saimirÃ-11. At middle
and late times (Fig. 3) after infection, sera from the experimental
hosts precipitated a limited number of viral proteins: p152, p127,
p115, p80, p55-57 (p55 for A. trivirgatus, p57 for S. nigricollis
and NZWR), p53, p50, p28. p146 and p135 were precipitated
with some owl monkey sera only in very reduced amounts; p195,
p123, p106, p97, p88, p67, and p61 were never seen. Three
proteins, however, were not found to be precipitated with the
sera of the natural hosts: p115, p80, p55-57. p115 and p55-57
are already synthesized at an early stage after infection [6 to 8
hr p.i. (Fig. 2)]. In the presence of azetidine, p115 is not synthe
sized (Fig. 1).
Precipitation with Serum of an Animal Infected with H.
saimirÃ-11 att. H. saimirÃ-11-infected cell proteins were precipi
tated with a serum of a S. fuscicollis (Sf 1), ./hich was persistently
infected with H. saimirÃ-11 att. The protein profiles obtained after
precipitation were very similar to those obtained with the sera of
SaimirÃ-sciureus, most of the proteins being structural polypep
tides (Figs. 1 to 3).
Comparison of H. saimirÃ-11- and H. saimirÃ-11 alt-infected
Cell Proteins. All sera from the natural and experimental hosts
showed no difference in the protein profiles of H. saimirÃ-11- and
H. saimirÃ-11 att-infected cell proteins. By immunoprecipitation
with a serum prepared against H. saimirÃ-11-infected cell proteins
in a goat (Fig. 4), one polypeptide was precipitated in H. saimirÃ-
11-infected cells which was not found in H, saimirÃ-11 att-infected
cells; the protein had a molecular weight of about 55,000.
DISCUSSION
In this study, we determined the specificity of antibodies in
various experimental (S. nigricollis, S. fuscicollis, A. trivirgatus,
NZWR) and natural (SaimirÃ-sciureus) hosts by immunoprecipi
tation of proteins. These polypeptides were obtained from OMK
cells infected with H. saimirÃ-11 orH. saimirÃ-11 att in the presence
of [35S]methionine at different times after infection. In the natural
hosts, most antibodies are directed against late viral polypeptides
(Fig. 3), which are mostly structural proteins of the H. saimirÃ-
virion (13): p195, p152, p146, p135, p127, p123, p106, p97,
p88, p67, p61, p53, p50, p28.
A very similar picture was obtained with a serum from a S.
fuscicollis (Sf 1), which was infected with H. saimirÃ-11 att and
developed a lifelong virus carrier status. H. saimirÃ-11 att (17) is
reported to be nononcogenic in different marmoset species,
induces a latent or persistent infection, and protects animals
against challenge inoculation with H. saimirÃ-11 (4,18,19). Thus,
the etiological behavior of H. saimirÃ-11 att in marmosets is very
similar to that of H. saimirÃ-11 in SaimirÃ-sciureus monkeys. This
fact could be demonstrated by the results obtained for the
immunoprecipitation experiments. The sera of squirrel monkeys
infected with the oncogenic wild type showed the same antibody
pattern as that obtained from a marmoset infected with H. saimirÃ-
11 att.
Sera from experimental hosts infected with H. saimirÃ-11 which
had died from a neoplastic disease showed after immunoprecip
itation that their antibody specificity was different from that
obtained from the natural host but very similar among the differ
ent species (NZWR, owl monkey, marmoset). With the sera of
all these hosts, 3 proteins were precipitated which were never
precipitated with sera from squirrel monkeys: p115, p80, and
p55 in owl monkeys; and p57 in S. nigricollis and NZWR,
respectively. The slight difference in the molecular weight (p55-
p57) may be due to a different modification of the protein in the
various hosts with the antibodies directed against the modifica
tion. p115 and p55-p57 were synthesized at an early stage after
infection (Fig. 2); the synthesis of p115, however, was inhibited
by the treatment with azetidine (Fig. 1) and thus may belong to
a second group of early proteins.Since all animals developing a H. sa/m/r/'-induced neoplastic
disease are reported to have high anti-EA titers (8,14,15) which
increase with the development of malignant tumors, one might
conclude that the 3 proteins p115, p80, and p55-57 are com
ponents of the EA complex. In the natural hosts, the anti-EA
titers were found to decline ten months after the primary infec
tion; this is very similar to the serological data for Epstein-Barr
virus in humans, where rising anti-EA titers are a prognos-
tically unfavorable sign indicating neoplastic proliferation (5, 6).
Between the protein profiles obtained from H. saimirÃ-11- and
H. saimirÃ-11 att-infected cell proteins precipitated with squirrel
monkey, owl monkey, marmoset, and NZWR sera, respectively,
no differences could be detected. Precipitation with a goat serum
against H. saimirÃ- 11-infected cells produced, however, one
protein that could be identified in H. saimirÃ- 11-infected cells
which was not synthesized in H. saimirÃ-11 att-infected cells (Fig.
4). The molecular weight of the protein was found to be 55,000.
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This protein may either be a viral protein, which is deleted in H.
saimirÃ-11 att, or a cellular polypeptide the synthesis of which is
not induced during infection with H. saimirÃ-11 att. As a third
possibility, the differences in the protein patterns may be due to
a different protein modification of H. saimirÃ-11- and H. saimirÃ-11
att-induced polypeptides.
The characterization of the polypeptides which present them
selves in the various experimental and natural hosts as antigens
may be a step towards a better understanding of the regulatory
mechanisms involved in the development of the H. saimiri-m-
duced malignant disease. At least these experiments show that
tests for antibodies directed against specific antigens could be
used to discriminate between tumor-bearing and non-tumor-
bearing hosts and that antibodies reacting with other antigens
are of use for a nondiscriminatingdiagnosis of the immune status.
Although this may be of greatest importance for hosts infected
with H. saimirÃ-,similar work may prove very useful for the
diagnosis of infectious or neoplastic disease caused by Epstein-
Barr virus and other herpesviruses in humans.
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Fig. 1. H. sa/m/ri-infected OMK cells treated with azetidine (500 ^g/ml), labeled with ["SJmethionine (20 nCi/ml) from 24 to 26 hr after infection, and immunoprecipitated
with the sera indicated. 77, H. sa/m/ri-11 infected cells; art, H. saimirÃ-11 infected cells; Ss 7, Ss 2, Ss 3, sera of SaimirÃ-sciureus, infected with H. saimirÃ-11; At 7, At 2,
At 3, sera of A. trivirgatus, infected with H. saimirÃ-11 ; Sn 7, serum of S. nigricollis, infected with H. saimirÃ-11 ; Sf 1, serum of S. fuscicollis, infected with H. saimirÃ-11 att;
NZWR 7, serum of a NZWR, infected with H. saimirÃ-11; R1, rabbit serum against structural proteins of H. saimirÃ-11.
Fig. 2. H. sa/m/ri-infected OMK cells, labeled with ["SJmethionine (20 nCi/ml) from 6 to 8 hr after infection, and Â¡mmunoprecipitated with the sera indicated. For
identification of abbreviations, see legend to Fig. 1.
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Fig. 3. H. sa/m/ri-infected OMK cells, labeled with (35S]methionine (20 ^Ci/ml) from 24 to 26 hr after infection, and immunoprecipitated with the sera indicated. For
identification of abbreviations, see legend to Fig. 1.
Fig. 4. OMK cells infected with H. saimirÃ-,labeled at various times after infection with [^SJmethionine (20 nCi/ml), and immunoprecipitated with a goat serum directed
against H. saimirÃ-11-infected cell proteins. A, mock-infected cells, labeled 24 to 26 hr after mock infection; B, H. saimirÃ-11-infected cells, labeled 8 to 10 hr after infection;
C. H. saimirÃ-11-infected cells, labeled 24 to 26 hr after infection; D, H. saimirÃ-11 att-infected cells, labeled 8 to 10 hr after infection; Â£,H, saimirÃ-11 att-infected cells,
labeled 24 to 26 hr after infection.
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